Journal article
A vaccine against serogroup B Neisseria meningitidis: Dealing with uncertainty
- Abstract:
-
Neisseria meningitidis is an important cause of invasive bacterial infection in children worldwide. Although serogroup C meningococcal disease has all but disappeared in the past decade as a direct result of immunisation programmes in Europe, Canada, and Australia, meningitis and septicaemia caused by serogroup B meningococci remain uncontrolled. A vaccine (4CMenB) has now been licensed for use in the European Union, comprising three immunogenic antigens (identified with use of reverse vaccin...
Expand abstract
Actions
Authors
Bibliographic Details
- Publisher:
- Lancet
- Journal:
- Lancet Infectious Diseases
- Volume:
- 14
- Issue:
- 5
- Pages:
- 426-434
- Publication date:
- 2014-01-01
- DOI:
- EISSN:
-
1474-4457
- ISSN:
-
1473-3099
Item Description
- Language:
- English
- Pubs id:
-
pubs:464285
- UUID:
-
uuid:36bcb8f9-3527-402e-918f-bd83af2b26af
- Local pid:
- pubs:464285
- Source identifiers:
-
464285
- Deposit date:
- 2014-05-26
Terms of use
- Copyright date:
- 2014
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record